TY  - JOUR 
AU  - Lejeune, M.
AU  - Reverté, L.
AU  - Gallardo, N.
AU  - Sauras, E.
AU  - Bosch, R.
AU  - Mata, D.
AU  - Roso, A.
AU  - Petit, A.
AU  - Peg, V.
AU  - Riu, F.
AU  - García-Fontgivell, J.
AU  - Relea, F.
AU  - Vieites Pérez-Quintela, María Begoña
AU  - de la Cruz-Merino, L.
AU  - Arenas, M.
AU  - Rodriguez, V.
AU  - Galera, J.
AU  - Korzynska, A.
AU  - Plancoulaine, B.
AU  - Álvaro, T.
AU  - López, C.
PY  - 2023
SN  - 1422-0067
UR  - http://hdl.handle.net/20.500.11940/21723
AB  - Triple-negative breast cancer (TNBC) is particularly challenging due to the weak or absent response to therapeutics and its poor prognosis. The effectiveness of neoadjuvant chemotherapy (NAC) response is strongly influenced by changes in elements of...
LA  - eng
KW  - Humans
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Matrix Metalloproteinase 9
KW  - Neoadjuvant Therapy
KW  - Neoplasm, Residual
KW  - Triple Negative Breast Neoplasms
KW  - Tumor Microenvironment
TI  - Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients
DO  - 10.3390/ijms241411297
T2  - International Journal of Molecular Sciences
KW  - AS Lugo
KW  - HP Monforte
VL  - 24
ER  -